Aggressive pharmacological treatment for reversing malignant bowel obstruction
Authors:
- 1 October 2004
- journal article
- clinical trial
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 28 (4) , 412-416
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Therapeutic Value of Gastrografin in Adhesive Small Bowel Obstruction After Unsuccessful Conservative TreatmentAnnals of Surgery, 2002
- Surgery for the resolution of symptoms in malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer2000
- Role of Octreotide, Scopolamine Butylbromide, and Hydration in Symptom Control of Patients with Inoperable Bowel Obstruction and Nasogastric TubesJournal of Pain and Symptom Management, 2000
- The use of steroids in the management of inoperable intestinal obstruction in terminal cancer patients: do they remove the obstruction?Palliative Medicine, 2000
- Systematic review and meta-analysis of corticosteroids for the resolution of malignant bowel obstruction in advanced gynaecological and gastrointestinal cancersAnnals of Oncology, 1999
- Water-soluble contrast study predicts the need for early surgery in adhesive small bowel obstructionBritish Journal of Surgery, 1998
- Pitfalls in placebo-controlled trials in palliative care: dexamethasone for the palliation of malignant bowel obstructionPalliative Medicine, 1998
- Octreotide may prevent definitive intestinal obstructionJournal of Pain and Symptom Management, 1997
- Water-soluble contrast material has no therapeutic effect on postoperative small-bowel obstruction: Results of a prospective, randomized clinical trialThe American Journal of Surgery, 1996
- Symptom control in terminally ill patients with malignant bowel obstruction (MBO)Journal of Pain and Symptom Management, 1994